Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,761 | -116,835 | -98,688 | -96,749 | -97,483 |
| Depreciation Amortization | 19,846 | 18,523 | 18,435 | 14,156 | 9,819 |
| Accounts receivable | 52,596 | 2,252 | -3,187 | -13,091 | -8,338 |
| Accounts payable and accrued liabilities | 2,055 | -6,305 | 3,247 | 177 | 5,802 |
| Other Working Capital | 53,665 | 48,858 | -5,723 | -12,297 | -21,828 |
| Other Operating Activity | -68,412 | 28,761 | -1,528 | 3,242 | 31,766 |
| Operating Cash Flow | $22,989 | $-24,746 | $-87,444 | $-104,562 | $-80,262 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -98,962 | -13,363 | N/A | 15,000 | -6,706 |
| PPE Investments | -2,583 | -1,073 | -2,431 | -18,543 | -45,639 |
| Net Acquisitions | N/A | 79 | -446 | 10,979 | N/A |
| Purchase Of Investment | -2 | 489 | 126 | -143 | -1,430 |
| Purchase Sale Intangibles | -1,260 | N/A | -10 | -13 | -567 |
| Other Investing Activity | -1,261 | -1,642 | -10 | -14 | -567 |
| Investing Cash Flow | $-102,808 | $-15,510 | $-2,761 | $7,279 | $-54,342 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 23,201 | 29,671 | 5,750 | N/A | N/A |
| Debt Repayment | -5,001 | -5,107 | -1,343 | N/A | 24,170 |
| Common Stock Issued | 82,822 | 67,936 | -569 | 56,239 | 9,759 |
| Other Financing Activity | -11,909 | -9,635 | -2,693 | -8,714 | -6,607 |
| Financing Cash Flow | $89,113 | $82,865 | $1,145 | $47,525 | $27,322 |
| Exchange Rate Effect | -2,752 | 884 | -3,360 | -5,754 | 7,908 |
| Beginning Cash Position | 136,708 | 93,216 | 185,636 | 241,148 | 340,522 |
| End Cash Position | 143,251 | 136,708 | 93,216 | 185,636 | 241,148 |
| Net Cash Flow | $6,543 | $43,492 | $-92,420 | $-55,512 | $-99,374 |
| Free Cash Flow | |||||
| Operating Cash Flow | 22,989 | -24,746 | -87,444 | -104,562 | -80,262 |
| Capital Expenditure | -2,583 | -1,073 | -2,431 | -18,543 | -45,693 |
| Free Cash Flow | 20,406 | -25,819 | -89,875 | -123,105 | -125,955 |